C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A01K 67/027 (2006.01) C12N 15/10 (2006.01) C12N 15/85 (2006.01)
Patent
CA 2295865
The invention concerns a method for diagnosing Alzheimer disease, consisting in demonstrating one or several mutations in the genomic DNA region regulating the expression of the apolipoprotein E gene, inducing a modification of the apolipoprotein E gene, with respect to a control population or a modification of the expression relative to the alleles of the apolipoprotein E gene.
Cette invention concerne un procédé de diagnostic de la maladie d'Alzheimer, comprenant la mise en évidence d'une ou plusieurs mutations dans la région d'ADN génomique de régulation de l'expression du gène de l'apolipoprotéine E, induisant une modification de l'expression du gène de l'apolipoprotéine E, par rapport à une population témoin ou une modification de l'expression relative des allèles du gène de l'apolipoprotéine E.
Amouyel Philippe
Chartier-Harlin Marie-Christine
Lambert Jean-Charles
Institut National de La Sante Et de La Recherche Medicale (inser
Institut Pasteur de Lille
Robic
LandOfFree
Method for diagnosing alzheimer disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for diagnosing alzheimer disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosing alzheimer disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1505171